| Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double‐blind, placebo‐controlled trial JM Meijer, PM Meiners, A Vissink, FKL Spijkervet, W Abdulahad, ... Arthritis & Rheumatism 62 (4), 960-968, 2010 | 622 | 2010 |
| Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study) PM Meiners, A Vissink, FGM Kroese, FKL Spijkervet, NS Smitt-Kamminga, ... Annals of the rheumatic diseases 73 (7), 1393-1396, 2014 | 276 | 2014 |
| Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission WH Abdulahad, CA Stegeman, PC Limburg, CGM Kallenberg Arthritis & Rheumatism: Official Journal of the American College of …, 2008 | 230 | 2008 |
| Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission WH Abdulahad, CA Stegeman, YM van der Geld, ... Arthritis & Rheumatism 56 (6), 2080-2091, 2007 | 212 | 2007 |
| Disturbed Th1, Th2, Th17 and Treg balance in patients with systemic lupus erythematosus S Dolff, M Bijl, MG Huitema, PC Limburg, CGM Kallenberg, ... Clinical Immunology 141 (2), 197-204, 2011 | 204 | 2011 |
| Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis WH Abdulahad, YM van der Geld, CA Stegeman, CGM Kallenberg Kidney international 70 (5), 938-947, 2006 | 185 | 2006 |
| Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis WH Abdulahad, YM van der Geld, CA Stegeman, CGM Kallenberg Kidney international 70 (5), 938-947, 2006 | 185 | 2006 |
| B-cell hyperactivity in primary Sjögren's syndrome FGM Kroese, WH Abdulahad, E Haacke, NA Bos, A Vissink, H Bootsma Expert review of clinical immunology 10 (4), 483-499, 2014 | 179 | 2014 |
| Attenuation of follicular helper T cell–dependent B cell hyperactivity by abatacept treatment in primary Sjögren's syndrome GM Verstappen, PM Meiners, OBJ Corneth, A Visser, S Arends, ... Arthritis & rheumatology 69 (9), 1850-1861, 2017 | 158 | 2017 |
| Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis ER Popa, CA Stegeman, WH Abdulahad, B Van Der Meer, J Arends, ... Oxford University Press 46 (6), 1029-1033, 2007 | 158 | 2007 |
| Frequencies and role of regulatory T cells in patients with (pre) malignant cervical neoplasia J Visser, HW Nijman, BN Hoogenboom, P Jager, D Van Baarle, ... Clinical & Experimental Immunology 150 (2), 199-209, 2007 | 151 | 2007 |
| Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus S Dolff, WH Abdulahad, J Westra, B Doornbos-van der Meer, PC Limburg, ... Arthritis research & therapy 13, 1-10, 2011 | 145 | 2011 |
| Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus S Dolff, WH Abdulahad, J Westra, B Doornbos-van der Meer, PC Limburg, ... Arthritis research & therapy 13, 1-10, 2011 | 145 | 2011 |
| Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica KSM van der Geest, WH Abdulahad, P Chalan, A Rutgers, G Horst, ... Arthritis & Rheumatology 66 (7), 1927-1938, 2014 | 144 | 2014 |
| Aging disturbs the balance between effector and regulatory CD4+ T cells KSM van der Geest, WH Abdulahad, SM Tete, PG Lorencetti, G Horst, ... Experimental gerontology 60, 190-196, 2014 | 137 | 2014 |
| Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica KSM van der Geest, WH Abdulahad, A Rutgers, G Horst, J Bijzet, ... Rheumatology 54 (8), 1397-1402, 2015 | 133 | 2015 |
| Urinary soluble CD163 in active renal vasculitis VP O’Reilly, L Wong, C Kennedy, LA Elliot, S O’Meachair, AM Coughlan, ... Journal of the American Society of Nephrology 27 (9), 2906-2916, 2016 | 127 | 2016 |
| Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell-type specificity B Hrdlickova, V Kumar, K Kanduri, DV Zhernakova, S Tripathi, ... Genome medicine 6, 1-14, 2014 | 119 | 2014 |
| Urinary CD4+ effector memory T cells reflect renal disease activity in antineutrophil cytoplasmic antibody–associated vasculitis WH Abdulahad, CGM Kallenberg, PC Limburg, CA Stegeman Arthritis & Rheumatism 60 (9), 2830-2838, 2009 | 111 | 2009 |
| Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention CGM Kallenberg, CA Stegeman, WH Abdulahad, P Heeringa American Journal of Kidney Diseases 62 (6), 1176-1187, 2013 | 108 | 2013 |
